These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23229365)

  • 1. Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection.
    Ghosh BD; Swaminathan RV; Kim LK; Feldman DN
    Minerva Med; 2012 Dec; 103(6):431-9. PubMed ID: 23229365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M; Airoldi F; Zimarino M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
    Silber S
    Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.
    De Luca G; Suryapranata H; Marino P
    Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reperfusion strategies in ST-segment elevation myocardial infarction.
    Stiermaier T; Desch S; Schuler G; Thiele H; Eitel I
    Minerva Med; 2013 Aug; 104(4):391-411. PubMed ID: 24008602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
    De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
    Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.
    Singh T; Cuomo L; Cohen M; Ahmad HA; Aronow WS
    Curr Clin Pharmacol; 2013 Feb; 8(1):59-66. PubMed ID: 22946865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.
    Kübler P; Jankowska EA; Ferenc M; Ponikowski P; Banasiak W; Reczuch K
    Kardiol Pol; 2013; 71(1):25-31. PubMed ID: 23348530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of drug eluting stents versus bare metal stents in ST-elevation myocardial infarction: a contemporary review.
    Bokhoor PI; Lee MS
    Minerva Cardioangiol; 2011 Feb; 59(1):49-59. PubMed ID: 21285931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature.
    Ehdaie A; Lee MS
    Minerva Cardioangiol; 2009 Oct; 57(5):645-55. PubMed ID: 19838154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ; Sattur S; Orshaw P; Boura J
    J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
    Assali A; Vaduganathan M; Vaknin-Assa H; Lev EI; Brosh D; Teplitsky I; Bental T; Battler A; Kornowski R
    Am J Cardiol; 2012 Jun; 109(11):1563-8. PubMed ID: 22440117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
    Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.